Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
63 hedge funds and large institutions have $173M invested in Alpine Immune Sciences Inc in 2015 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 8 closing their positions.
275% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 8
54% more funds holding
Funds holding: 41 → 63 (+22)
0% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 13
6% less capital invested
Capital invested by funds: $184M → $173M (-$10.9M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TM
Tiger Management
New York
|
+$10.7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$8.48M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.88M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.63M |
| 5 |
PA
Perceptive Advisors
New York
|
+$2.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCP
Lamond Capital Partners
San Francisco,
California
|
-$3.41M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$2.37M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$2.16M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.04M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.52M |
ALPN Hedge Fund Activity: Q3 2015 in Review
63 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q3 2015, worth a combined $173M — down 5.9% from $184M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new ALPN positions and 8 closed out — a net gain of 22 holders — while 13 added to existing stakes and 13 trimmed.
The largest buyer was Tiger Management, opening a new position worth an estimated $10.7M. The largest seller was Lamond Capital Partners, exiting entirely with an estimated $3.41M sold.
- 63 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q3 2015, up from 41 in Q2 2015.
- Funds reported $173M of Alpine Immune Sciences Inc stock for Q3 2015, down 5.9% quarter-over-quarter.
- 30 funds opened new Alpine Immune Sciences Inc positions in Q3 2015 and 8 closed out, a net change of +22 holders.
- The largest Alpine Immune Sciences Inc buyer in Q3 2015 was Tiger Management, an estimated $10.7M added.
- The largest Alpine Immune Sciences Inc seller in Q3 2015 was Lamond Capital Partners, an estimated $3.41M sold.
Based on aggregated 13F filings for Q3 2015.